Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine - Schloer, S; Brunotte, L; Goretzko, J (Emerg Microbes Infect, 2020)
et al.